← boothcheck All Stocks

UHS

UNIVERSAL HEALTH SERVICES, INC.

UNIVERSAL HEALTH SERVICES, INC. (UHS) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.

Live priced in
temporarily suppressed
Priced In
within-range

Key Takeaways

• Universal Health Services runs two hospital businesses, acute care and behavioral health, with acute care, outpatient, and commercial insurer revenue making up roughly 57% of consolidated net revenues, per the filing, and behavioral health the rest. • The striking fact is the valuation gap: the stock trades at a fraction of where the standard methods land even as Q1 2026 revenue grew 9.6% and EPS rose 16.1% to $5.62 [Source: UHS Q1 2026 results, 2026], a growth profile the price does not refle

View Full Report →

Is UHS overvalued? See what's priced in →

Institutional ownership

633 institutional managers reported holding UHS in 13F filings for the quarter ended 2026-03-31. Together they hold about 83% of the company; the top 10 hold 45%. 58 opened new positions that quarter. Held by Vanguard Group, First Eagle Investment Management, BlackRock, among others. On the short side, 2.6M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (2.4 days of typical volume to cover).

Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.

Capital returns

UHS has cut its share count 27.5% over the past five years, spending $4.04B on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting); the current rate is $0.80 a share annually. Cash returned over the past three years: $144.80M in dividends and $2.14B in repurchases.

Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.

Insider activity

Open-market insider buys at UHS over the trailing three years: 2023: 1 buy totaling $34k. 10 officers and directors are on file.

Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.

Earnings reactions

UHS's recent reports: the day-one move, then what the following quarter actually did.

reportday onenext quarter
2023-05-09+3.6%+6.7%
2023-08-09-7.8%-3.5%
2023-11-09+0.9%+23.5%
2024-02-28-1.6%+5.2%

Day-one is the close-to-close move around the filing. Nothing here is investment advice.

Recent filings

UHS's latest 8-K filings: 2026-05-22 (items 5.07); 2026-05-21 (items 5.02); 2026-04-28 (items 2.02, 9.01); 2026-04-24 (items 1.01, 2.03, 9.01); 2026-03-30 (items 5.02).

Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.

Compare UHS

BTSG vs UHSCHE vs UHSCON vs UHSEHC vs UHSENSG vs UHSFMS vs UHS

Last analyzed: June 28, 2026

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.